Gordon Gary B.

Insider profile

Performance

Overall performance
3.4

Performance over holding periods
3.4
30 days 90 days 120 days
Average return 71% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Gordon Gary B.'s trades of TriSalus Life Sciences Inc's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
442.92
Quantity 31,857 +47.7%
Value US$3,792,032
Transaction date
Purchase
Price
312.75
Quantity 34,398 -34.7%
Value US$4,083,115
Transaction date
Planned sale
Price
129.29
Quantity 1,855 +42.9%
Value US$4,207,799
Transaction date
Planned sale
Price
15.03
Quantity 3,000 -26.0%
Value US$45,084
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-18 2026-05-15 B Purchase
31,857 +47.7%
442.92
US$3,792,032
31,857 +47.7% 442.92 US$3,792,032
2026-02-23 2026-02-23 B Purchase
34,398 -34.7%
312.75
US$4,083,115
34,398 -34.7% 312.75 US$4,083,115
2021-02-26 2021-02-24 PlS Planned sale
1,855 +42.9%
129.29
US$4,207,799
1,855 +42.9% 129.29 US$4,207,799
2021-01-22 2021-01-20 PlS Planned sale
3,000 -26.0%
15.03
US$45,084
3,000 -26.0% 15.03 US$45,084